Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin 7 pseudogene 13 (SEPTIN7P13) is a noncoding pseudogene, related in sequence to the functional Septin 7 gene. Pseudogenes are nonfunctional segments of DNA that resemble working genes but typically lack protein-coding potential due to mutations, truncations, or loss of regulatory elements[3][5]. Although historically viewed as “junk DNA,” pseudogenes may regulate cellular processes through RNA-based mechanisms, such as serving as sources of siRNAs or acting as microRNA decoys, which can modulate their parent gene expression and potentially play roles in cancer and other diseases[1]. However, there is no direct evidence of specific biological or disease-associated functions for SEPTIN7P13 itself, and it is not considered a canonical molecular target for therapy or diagnostics. Key clarifications: - SEPTIN7P13 is not a functional septin protein, receptor, or enzyme—it is a pseudogene. - Standard target-related data (drugs, mechanism, safety, biomarkers) do not apply[3][5]. - While pseudogenes can have regulatory functions, these are indirect and typically not actionable for drug discovery unless direct RNA-based roles are established[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin 7 pseudogene 13 (SEPTIN7P13).